Boast­ing a late-stage Botox me-too, Evo­lus files for $75M IPO

Seek­ing to break Al­ler­gan’s dom­i­nance in the wrin­kle-re­duc­ing mar­ket, Evo­lus has filed for a $75 mil­lion IPO. As the Irvine, CA-based biotech is prepar­ing to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER